Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 2;10(9):2179.
doi: 10.3390/biomedicines10092179.

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics

Ellenmae W X Leong  1 , Ruowen Ge  1
Affiliations
Review

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics

Ellenmae W X Leong et al. Biomedicines. .

Abstract

Lipid nanoparticles (LNPs) have emerged as a powerful non-viral carrier for drug delivery. With the prevalence of respiratory diseases, particularly highlighted by the current COVID-19 pandemic, investigations into applying LNPs to deliver inhaled therapeutics directly to the lungs are underway. The progress in LNP development as well as the recent pre-clinical studies in three main classes of inhaled encapsulated drugs: small molecules, nucleic acids and proteins/peptides will be discussed. The advantages of the pulmonary drug delivery system such as reducing systemic toxicity and enabling higher local drug concentration in the lungs are evaluated together with the challenges and design considerations for improved formulations. This review provides a perspective on the future prospects of LNP-mediated delivery of inhaled therapeutics for respiratory diseases.

Keywords: inhalation drug delivery; lipid nanoparticles (LNPs); lung; respiratory diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Visual illustration of the structures and composition of various LNPs. (A) Liposome. (B) Drug-loaded liposome. (C) Targeted liposome. (D) PEGylated liposome. (E) Solid lipid nanoparticle. (F) Nanostructured lipid carrier. Created with BioRender.com.
Figure 2
Figure 2
A summary of inhaled LNP-encapsulated drugs that have been investigated for respiratory diseases in animal models. Created with BioRender.com. ALI: Acute lung injury; ARDS: acute respiratory distress syndrome; COPD: chronic obstructive pulmonary disease; CF: Cystic fibrosis; IPF: idiopathic pulmonary fibrosis; LAM: lymphangioleiomyomatosis; LNP: lipid nanoparticle; NSCLC: non-small cell lung carcinoma; PAH: pulmonary arterial hypertension; PCD: primary ciliary dyskinesia; SLN: solid lipid nanoparticles; NLC: nanostructured lipid carriers; VIP: vasoactive intestinal peptide.
Figure 3
Figure 3
Schematic summary of AD-dependent deposition and distribution mechanisms of inhaled LNP aggregates in the airways. The mechanisms are inertial impaction, gravitation sedimentation and Brownian diffusion. Subsequent cellular uptake of individual LNPs and drug payloads by dissociation, endocytosis and membrane fusion facilitate therapeutic action (PEGylated and targeted liposome depicted). AD: aerodynamic diameter. Created with BioRender.com.
See this image and copyright information in PMC

References

    1. Forum of International Respiratory Societies . The Global Impact of Respiratory Disease. 2nd ed. European Respiratory Society; Sheffield, UK: 2017.
    1. WHO Asthma. [(accessed on 29 August 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/asthma.
    1. WHO The Top 10 Causes of Death. [(accessed on 24 May 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
    1. WHO Chronic Obstructive Pulmonary Disease (COPD) [(accessed on 25 December 2020)]. Available online: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...
    1. World Health Organization . Chronic Respiratory Diseases. World Health Organization; Geneva, Switzerland: [(accessed on 9 June 2021)]. Available online: https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1.

LinkOut - more resources